1. Home
  2. BIO vs ATI Comparison

BIO vs ATI Comparison

Compare BIO & ATI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • ATI
  • Stock Information
  • Founded
  • BIO 1952
  • ATI 1960
  • Country
  • BIO United States
  • ATI United States
  • Employees
  • BIO N/A
  • ATI N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • ATI Steel/Iron Ore
  • Sector
  • BIO Industrials
  • ATI Industrials
  • Exchange
  • BIO Nasdaq
  • ATI Nasdaq
  • Market Cap
  • BIO 9.1B
  • ATI 8.0B
  • IPO Year
  • BIO N/A
  • ATI N/A
  • Fundamental
  • Price
  • BIO $342.23
  • ATI $57.67
  • Analyst Decision
  • BIO Strong Buy
  • ATI Buy
  • Analyst Count
  • BIO 4
  • ATI 8
  • Target Price
  • BIO $414.00
  • ATI $74.83
  • AVG Volume (30 Days)
  • BIO 158.1K
  • ATI 1.5M
  • Earning Date
  • BIO 02-13-2025
  • ATI 02-04-2025
  • Dividend Yield
  • BIO N/A
  • ATI N/A
  • EPS Growth
  • BIO N/A
  • ATI N/A
  • EPS
  • BIO N/A
  • ATI 2.61
  • Revenue
  • BIO $2,580,209,000.00
  • ATI $4,253,399,999.00
  • Revenue This Year
  • BIO N/A
  • ATI $4.22
  • Revenue Next Year
  • BIO $2.92
  • ATI $6.71
  • P/E Ratio
  • BIO N/A
  • ATI $21.66
  • Revenue Growth
  • BIO N/A
  • ATI 3.24
  • 52 Week Low
  • BIO $262.12
  • ATI $38.04
  • 52 Week High
  • BIO $387.99
  • ATI $68.92
  • Technical
  • Relative Strength Index (RSI)
  • BIO 53.78
  • ATI 52.23
  • Support Level
  • BIO $335.42
  • ATI $54.49
  • Resistance Level
  • BIO $351.96
  • ATI $57.42
  • Average True Range (ATR)
  • BIO 9.09
  • ATI 1.16
  • MACD
  • BIO 2.06
  • ATI 0.18
  • Stochastic Oscillator
  • BIO 59.23
  • ATI 73.62

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several major end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

Share on Social Networks: